He Junli
CEO
He Junli has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.
On the most recent filing, He Junli is listed as CEO at Harvard Apparatus Regenerative Technology, Inc. Inside the rolling window, He Junli reported 4 open-market purchases totaling $400K in HRGN and no open-market sales. The largest disclosed transaction in the window is a purchase of 361,905 HRGN shares on Sep 11, 2026, worth $380K.
Companies traded
Insider Buying
$400K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has He Junli made?
He Junli has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does He Junli trade?
He Junli has filed SEC Form 4 disclosures for 1 company, including HRGN.
When was He Junli's most recent SEC Form 4 filing?
He Junli's most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.
What is He Junli's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, He Junli is listed as CEO.
What is He Junli's total buy and sell value in the current window?
Inside the rolling retention window, He Junli bought $400K and sold $0 based on SEC Form 4 filings.
What was He Junli's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 361,905 HRGN shares on 2026-09-11, worth $380K, per SEC Form 4 filings.